Browsing Tag
CDK4/6 inhibitors
1 post
Lilly’s Verzenio hits overall survival milestone in early breast cancer after 2-year treatment
Verzenio improves survival in high-risk early breast cancer, confirms Eli Lilly. Find out how this changes the treatment landscape.